Research Projects

Worldwide, 50 million people suffer from dementia, which is caused by Alzheimer’s disease (AD) in 70% of the cases. There is no treatment to stop, reverse or prevent AD. AD is pathologically defined by amyloid plaques and tau tangles in the brain, implying that it is a single disease entity. Still, patients vary greatly in rate of decline and...

The goal of this project is to decipher the exact cellular and molecular mechanisms by which human microglia transduce toxicity to neurons in Alzheimer's disease (AD). Genetics revealed that microglia are one of the central players in the pathogenesis of AD. I and others have characterized the phenotypic response of microglia in AD using...

How can we recognize that a person with dementia is at the end of life? When we are dying, our physical, mental, and social abilities are gradually declining. No reliable method of predicting perceived dying currently exists although the technology is available (sensors, algorithms). The aim of Decoding Death and Dying in Dementia by Digital...

Our memory is essential for all aspects of our lives. Memories are encoded in the brain by coordinated neuronal activity in the hippocampus. Disruption of this coordination is associated with neurological/psychiatric disorders such as Alzheimer’s disease and schizophrenia affecting spatial and social memories. Emerging data suggests that the gut...

Alzheimers Disease (AD) is an adult-onset disorder characterized by progressive neuronal loss and synaptic dysfunction, leading to severe cognitive decline. Nuclear loss and pathological inclusions of TDP-43 protein have been identified in 20-50% of AD patients, which associate with higher odds of cognitive decline, and faster brain atrophy rates...

Five out of ten diseases leading to long term-disability are related to the brain, including stroke, depression or dementia. Despite tremendous progress in neurotechnology, there is still no effective treatment option available for many brain-related disorders. A very promising approach to treat brain disorders uses transcranial electric or...

In the brain, cells called astrocytes are as abundant as neurons, but are much less understood. Over the recent years, we have begun to appreciate how closely astrocytes support the development and function of synapses, the proposed substrate of memory. One emerging function of astrocytes is their direct involvement in learning and long-term memory...

"The COVID-19 pandemic continues to have a globally disproportionate impact on the well-being of people living with dementia particularly those who are community-dwelling who have seen reduced access to healthcare and increased risk of loneliness, isolation, and depression. Consequently, the 'home' has become a vital space of care that remains...

With an aging population and >55 million dementia cases worldwide; treatments are more needed than ever. However, effective treatments are lacking, with solutions only stalling dementia progress and no real disease-modifying effect. ATI has developed AT-001, a new drug with the potential to stop and revert the disease, and to delay its onset. AT...

ReST Therapeutics is a French biotech company founded late 2020 that develops breakthrough therapies to treat complex central nervous system disorders, in particular, Post-Traumatic Stress Disorder (PTSD) under its various forms followed by Alzheimer Disease (AD).Our lead candidate - FENM is a novel and proprietary chemical entity (NCE) targeting...

Alzheimer’s disease (AD) is the leading cause of dementia, affecting over 50 million people worldwide. Characterized by memory loss, cognitive decline, and the formation of amyloid-β plaques and neurofibrillary tangles, AD presents a significant global health burden. Current AD models, particularly in mice, fail to accurately represent the sporadic...

DORIAN GRAY project investigates the link between cardiovascular disease (CVD) and Mild Cognitive Impairment (MCI) in the ageing population. Its goal is to uncover underlying mechanisms to promote healthy, independent, and active living while reducing disease burden. Aligned with EU-Horizon Europe’s Strategic Plan on NCDs prevention, the project...